EPRX·29842P105·US·equity·Healthcare - Biotechnology-Activist
EPRX (EUPRAXIA PHARMACEUTICALS INC) is held by 29 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($9.8M), SCOTIA CAPITAL INC. ($7.2M), Point72 Asset Management, L.P. ($7M). Net institutional sentiment: Bullish.
See how EPRX's score breaks down across 4 SEC sources
Showing 1-20 of 32
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer